DeviceTalks Podcast Network

In this episode of the DeviceTalks Weekly Podcast, we speak with Yuriy Lebed, the CEO of Pharmaxi LLC, a CRO based in Kyiv, Urkaine, that works with pharmaceutical and medical device companies across the globe. In an interview from Lviv, Lebed says he was as shocked as many that Russia would invade its neighbor. The attack forced him to relocate with his family to Lviv, in the western part of the country. From there, he’s been able to lead the CRO as it keeps many clinical trials running. He calls the country’s regulators are “heroes” for vowing to process approvals while the capital city is bombed. He also says Pharmaxi is already planning for the future, which includes expanding operations into Poland and working within EU countries. You can find a way to donate to relief efforts for Ukraine here. https://www.forbes.com/advisor/personal-finance/donate-relief-to-ukraine

In this episode, we talk to two principals of Johnson & Johnson MedTech’s push to bring higher powered tech into its digital surgery strategy. In separate interviews, Johnson & Johnson Group CIO and Global VP of Medical Devices Larry Jones and Office of Digital Innovation Leader Peter Schulam (who also serves as global head of medical affairs, clinical affairs and pre-clinical research for Johnson & Johnson Medical Devices Cos.) explain how the company is moving toward the future. In our Newmarker’s Newsmakers segment, Jim Hammerand, managing editor of Medical Design and Outsourcing, tells us about his ongoing Cloud series. We first heard from Jones and Schulam in an MDO article. Link below. Jim also joins Chris Newmarker, executive editor of life sciences, and Tom Salemi, Editorial Director of DeviceTalks, in discussing medtech’s news of the week including news from robotic pill maker EndiaTx, Johnson & Johnson, Medtronic, DexCom and GE Healthcare and AliveCor. Also, listen for the code to save 25% off registration to DeviceTalks Boston and DeviceTalks Minnesota. TODAYS LINKS MDO Article - https://www.medicaldesignandoutsourcing.com/johnson-jnj-microsoft-cloud-larry-jones-peter-schulam/ Newsmaker #5 - https://www.medicaldesignandoutsourcing.com/endiatx-pillbot-stomach-cam-swims-torrey-smith/ Newsmaker #4 - https://www.massdevice.com/johnson-johnson-medical-devices-rebrand-medtech-jnj-name-change/ Newsmaker #3 - https://www.massdevice.com/medtronic-names-new-presidents-for-diabetes-surgical-robotics-cardiac-rhythm-units/ Newsmaker #2 - https://www.drugdeliverybusiness.com/dexcom-wins-ce-mark-for-next-gen-g7-cgm-will-begin-european-launch-within-weeks/ Newsmaker #1 - https://www.massdevice.com/ge-healthcare-alivecor-partner-to-reduce-cardiac-related-hospitalizations/ Donate to World Central Kitchen - https://wck.org/ Subscribe on all major podcast channels.

In this debut episode of the StrykerTalks Podcast series, Spencer Stiles, group president of orthopaedics and spine business at the medical device giant, reveals the mixture of art and science that went into successfully integrating Wright Medical into Stryker’s industry leading orthopedic business. What does Wright’s portfolio and personnel bring to the table? We’ll also talk about MAKO’s future. How will robotic surgery fit into healthcare delivery more broadly, and what does new complementary tech make possible.

In this week’s podcast, we’ll speak with Sally Saba, MD, Medtronic’s chief inclusion and diversity officer, about the company’s work to create a more welcoming – and better performing – workplace. Paul Grand, CEO of MedTech Innovator, returns to take part in Executive Editor’s Chris Newmarker’s Newsmaker session. We talk about hour industry’s response to Russia’s invasion of Ukraine, Ryan Egeland, MD, joining Big Sky Innovator, the top-performing companies of 2021, the collapse of another SPAC deal, and an eye-opening approval. https://www.medicaldesignandoutsourcing.com/how-medtech-and-pharma-are-responding-to-russias-invasion-of-ukraine/ https://www.massdevice.com/former-cardiovascular-systems-chief-medical-officer-joins-big-sky-biomedical-incubator/ https://www.massdevice.com/these-10-medtech-companies-stocks-performed-best-in-2021/ https://www.massdevice.com/memic-innovative-surgerys-spac-deal-is-off/ https://www.massdevice.com/alcon-launches-clareon-intraocular-lens-in-u-s/ BUY A MAMMOTH TOOTH FOR A GOOD CAUSE - https://www.newburyportnews.com/news/mammoth-find-for-gigantic-ukrainian-cause/article_bed30a28-a093-11ec-a3a2-370b99bd241b.html LEARN ABOUT DEVICETALKS BOSTON https://gateway.on24.com/wcc/eh/2927718/lp/3691568/were-back-an-insiders-look-into-bringing-back-a-better-devicetalks-boston SIGN UP to try to present at DeviceTalks Boston though the MedTech Innovator Program https://medtechinnovator.org/apply/

In this week’s episode of the DeviceTalks Weekly Podcast, Vafa Jamali, CEO of the newest medical device company ZimVie, speaks with Chris Newmarker, executive editor at MassDevice, about the companys’ plans post-spinout from Zimmer Biomet. Jamali explains where the company sees opportunities to compete in the spinal space. In addition to the interview, we talk about the medical device industry’s support of Ukraine, as it’s being invaded by Russia. If you want to support Ukrainians during this attack you can find some charities here. https://www.forbes.com/advisor/personal-finance/donate-relief-to-ukraine/ In our Newmarker’s Newsmaker’s segment we hit about news from Siemens Healthineers, Roche, Philips, Varian, Heartflow, and Butterfly Networks. If you want to see the agenda for DeviceTalks Boston go here. https://boston.devicetalks.com/ If you want to register for my webinar discussing our plans for our in-person DeviceTalks Boston meeting go here. https://gateway.on24.com/wcc/eh/2927718/lp/3691568/were-back-an-insiders-look-into-bringing-back-a-better-devicetalks-boston

In this episode, we’ll speak with Heather Hudnut Page, vice president and general manager of peripheral vascular at Philips about the company’s ongoing efforts to build an image-guided therapy program. Hudnut Page will walk us through the four sizable acquisitions Philips has made to build out its pipeline. We first visited Philips two years ago when we spoke with Chris Landon, Senior Vice President and Business Leader for Image-guided therapy devices. Chris Landon returns to the podcast to share his thoughts on this week’s Newsmarker’s Newsmakers. This week, Executive Editor Chris Newmarker highlighted the news from Baxter, Shockwave, Smith & Nephew, Medtronic, and Abbott. Subscribe to this podcast on any major podcast channel. You can listen to Chris Landon's interview here. https://www.devicetalks.com/philips-imaged-guided-leader-landon-shares-global-giants-plans-for-minimally-invasive-devices/

Welcome to the first ever DeviceTalks Weekly Pitchcast! This week Kwame Ulmer, executive director of Medtech Color, sits in on the Newsmaker segment and delivers details on the upcoming Medtech Color Pitch Contest. Then, you can hear from the contests finalists themselves - AllergenIQ, bTECH LLC, Candlelit Therapy, Dialysis-X, Diatech Diabetes, Free From Marketplace, SealCath, Sunny and TAB Diagnostics. You can watch the pitch competition on March 8 by registering at MedtechColor.org. Chris Newmarker's Newsmakers includes Philips, Boston Scientific, Bayliss, Johnson & Johnson, DePuy Synthes and Masimo. Subscribe to this podcast on every major podcast channel.

This week we’ll focus on a few of the exciting companies in the diabetes space. Associate Editor Sean Whooley first tracks down Dexcom CEO Kevin Sayer, who discusses the company’s next-generation G7 continuous glucose monitor, which is awaiting FDA approval. Then, Sean speaks with Bigfoot Biomedical CEO Jeffrey Brewer to learn more about what he calls “a transformational attempt” to simplify CGMs with an all-in-one platform with a smart insulin pen cap. Finally, Sean interviews Senseonics CMO Dr. Francine Kaufman about the company’s Eversense 180-day CGM, which just received FDA approval. Chris Newmarker brings his Newsmakers of the week including Amazon, Thermo Fisher, HeartFlow, Abbott, Cooper Company and Cook Medical. This episode was sponsored by Accumold. Subscribe to this podcast on major podcast channels.

In this episode we’ll interview Michael Friedrich, CEO of Distalmotion, creator of Dexter, a robotic system used for laparoscopic procedures. Friedrich details how Dexter is positioned to build a market in an area untapped by other surgical robotic systems. The company recently closed on a $90 million Series E led by Revival Healthcare and 415 Capital. (For a related podcast listen to our most recent episode of Intuitive Talks on your DeviceTalks Weekly Library.) Executive editor Chris Newsmaker delivers his Newsmaker’s Newsmakers – Boston Scientific, Medtronic, BD, Hologic and Senseonics. Find out how these companies are tied to the upcoming DeviceTalks Boston meeting and listen for the discount code. Subscribe to this podcast!

We drill down on diagnostics – including COVID-19 testing – with Dave Hickey, newly promoted executive vice president and president of the life sciences segment of BD and Brooke Story, who took over his post as worldwide president of integrated diagnostic solutions. How did BD handle the crushing demand for at-home tests and where is diagnostics headed in the future. Paul Grand, CEO of Medtech Innovator, sits in with Chris Newmarker and Tom Salemi on this week’s Newmarker’s Newsmakers. He also delivers some important deadlines for medical device startups. This week's Newsmakers include Medtronic, Edwards Lifesciences, Distal Motion, Respironics and ZimVie. Find out more about Medtech Innovator at MedtechInnovator.org. Register for DeviceTalks at devicetalks.com. Use the discount code mentioned in this episode! Subscribe to this podcast on any major podcast channel.

In this episode, we learn about Intuitive’s OTHER ground-breaking robot, the ION endoluminal system. This episode is sponsored by Maxon Group. ION allows for robot-assisted bronchoscopic procedures such as biopsies in the hardest to reach areas of the lung. The FDA cleared the ION system in 2019. We speak with Charlie Dean, vice president and general manager of the endoluminal business unit at Intuitive, an engineer who has spent his career working to make smaller, more effective minimally invasive tools. We also talk with Oliver Wagner, MD, vice president and medical officer of the endoluminal division. Wagner explains how his long-time pursuit of NOTES led him to join Intuitive. He also sees a future where ION can serve as a platform for many other devices. Subscribe to this podcast on every major podcast platform.

In this week’s DeviceTalks Weekly podcast, Outset Medical’s Leslie Trigg recounts the career detour that led her to a successful career in medical devices. Drawing on past experiences, the CEO explains why she chose to lead Outset’s mission to create a dialysis system that restore the freedom lost to the demand of traditional in-clinic dialysis. Outset’s “enterprise system” for dialysis now allows patients to treat themselves at home when and where they want. Can Outset serve as a model for other “hospital at home” approaches. Chris Newmarker delivers another stellar Newmarker’s Newsmakers featuring news from the Big 100, Edwards Life Sciences, Inspire Medical, Dexcom, Medtronic, Neurometrix, Augmedics and Acutus Medical. Subscribe on all major podcast channels.

In this episode, two senior orthopedics executives at DePuy Synthes walk us through the company’s growing portfolio. First, Rajit Kamal, worldwide president, sports medicine and shoulder reconstruction, lays out the opportunity for the growing shoulder market and explains what the INHANCE Shoulder System offers to surgeons. He also details what it will take for ortho companies to grow the shoulder market. Later, Andrew Ekdahl, Worldwide President, Joint Reconstruction, updates us on the company’s VELYS surgical robotic system. He explains how new digital and robotic tech will change the orthopedics industry. Instead of Newmarker’s Newsmakers, this week host Tom Salemi will review the most listened to DeviceTalks Weekly Episodes of 2021. We’ll also announce upcoming news in in-person conferences, digital meetings and podcasts – including a NEW podcast powered by DeviceTalks. Subscribe to all these podcasts at most major podcast platforms.

Happy New Year! In this first episode of 2022, we’ll learn a lot about Olympus Corp.’s plans to expand into the medtech industry. The global behemoth has been doubling down on the industry in recent years. COO Nacho Abia and Gabriela Kaynor, global division head of therapeutic solutions in the Americas, will lay out the plans to build into other parts of the medtech industry. Chris Newmarker is back with his Newmarker’s Newsmakers! Chris will bring news from Boston Scientific, GE Healthcare, Titan Medical, Relievant Medsystems, Medtronic, Memic Innovative Surgery, and Stryker. Subscribe to catch future episodes on any major podcast player.

In this episode, we’ll dive deep into the Heart Failure business at Abbott. First we’ll connect with Philip Adamson, MD, chief medical officer of the group. Dr. Adamson uses an explanation of CardioMEMS to give a vivid portrait of how patients live with heart failure. Technology, he says, makes turns those patients into their own health care workers. This podcast is sponsored by KNF. Then, we’ll talk with Kevin Bourque, vice president of research and development, and Robert Kormos, division VP, global affairs of heart failure, about the advances of Heartmate 3. Both also detail how Abbott is working to help children suffering from the condition. Dr. Kormos also shares the most gratifying part of his job. The entire editorial staff joins the podcast to share their personal top stories of 2021. News includes mentions from Vicarious Surgical, ResMed, Philips, Pfizer, BioNTech, Abbott, Dexcom and Insulet. Happy New Year!!! We'll see you in 2022. LIKE! FOLLOW! SUBSCRIBE!

In this episode we’ll explore potentially life-saving treatments for hypertension and stroke. First, we’ll talk with Sandra Saldana, CEO of the start-up Alva Health, which is developing a wearable system that can detect strokes. Alva Health won the 2021 Global Competition of the Medtech Innovator program. Then we’ll explore renal denervation, the exciting but vexing method of lowering hypertension by ablating nerves in the kidney. We’ll talk to the leaders in this space including Andy Weiss, CEO of Recor Medical, a division of Otsuka Holdings, that’s developing the Paradise Renal Denervation system. Weiss, a medtech veteran, shares his long-term views, one why he still sees Renal Denervation as a game-changer. Then, we’ll run an excerpt of the MedtronicTalks podcast interview with Jason Weidman, senior vice president and president of the coronary and renal denervation business at Medtronic. Weidman details Medtronic’s latest regulatory hiccups but, like Weiss, explains why he sees renal denervation as an important new therapy that can save the lives of people struggling to control their hypertension. You can listen to the entire interview with Weidman here. https://www.devicetalks.com/weidman-talks-us-through-the-long-road-to-get-symplicity-ready-to-help-patients-with-hypertension/.

In this episode, we learn about the data collecting during surgical robotic systems. Chief Digital Officer Brian Miller and Tony Jarc, Director, Research and Data Science , detail the importance of data being collected by Intuitive’s surgical robotic systems and how the company uses the data to help guide surgeons in the future.

In this episode, we’ll do a deep dive with Stryker Corp., which recently hosted an in-person analyst day. In our first interview Andy Pierce, group president of MedSurg and Neurotechnology, will update us on his group’s wide-ranging portfolio, including an artificial intelligence-enabled tool to save the lives of patients at risk of dying of post-partem hemorrhaging. Kevin Lobo, chair and CEO, visits next to update on the company’s plans to keep building on its market leader status. We’ll talk about the Wright Medical integration, what makes a good acquisition, and how the rise of surgical robotics is helping Stryker build out its MAKO product. In between all this, co-costs Tom Salemi and Chris Newmarker review this week’s Newmarker’s Newsmakers including items from GE Healthcare, Best Buy, the FDA, DePuy Synthes and Boston Scientific. We also talk about pie.

Just a short message from Tom and Chris, two grateful guys who don't like pumpkin sausage.

This week’s discussion begins on the stage in Las Vegas where Tom Salemi interviewed Kwame Ulmer of Ulmer Ventures and Medtech Color at Medmarc’s annual broker meeting. This episode is sponsored by Medmarc. The conversation hit upon five areas that have changed over the past two years due to the pandemic or critical concerns over equity and fairness. In this podcast, Ulmer speaks to the slow progress being made in medtech in diversifying the workforce. But he also offers signs of hope and introduced Medtech Color. Ulmer will also speak to improvements made at the FDA, where he started his medtech career. He also provides an update on a comprehensive survey of the FDA being conducted by the biomed program at UCLA. We’ll also hear post-conference interviews with Jennifer Fried, CEO of Explorer Surgical, who will share how that company successfully pivoted during the pandemic. Mark Leahey, CEO of MDMA, will update on the MCIT ruling that would deliver surer reimbursement for medical device companies with breakthrough products. Finally, Jonathan Norris of Silicon Valley Bank shares surprising changes to early and late-stage financings as well as medical device exits. Subscribe to this podcast on all major podcast applications.

In this week’s episode, we follow up on our first episode focused on Transcatheter Aortic Valve Replacement (TAVR). This time we speak with one of the market leaders, Medtronic, about their broad structural heart portfolio. Nina Goodheart, president of Structural Heart, walks us through each valve and explains why Medtronic is sponsoring a clinical trial pitting its aortic valve against a rival’s. We also hear from the new competitor on the block, Abbott, which recently earned FDA approval for its valve. Santosh Prabhu, PhD, introduces the new entry and explains why this work is so important to him personally.

In the second episode of IntuitiveTalks, two senior executives explain how the company gets surgeons and hospitals to understand the benefits of the Da Vinci system. EVP Dr. Myriam Curet, who describes herself as a late adopter of technology, shares why she opted to join Intuitive as CMO early on after trying the Da Vinci robot. Similarly, SVP Gillian Duncan, who heads physician training and development, says her early experience with the robotic system convince her to leave her academic career to join the robotics pioneer. Subscribe to this podcast on all major podcast applications.

This week we’ll hear from Chris Barry, CEO of NuVasive. Barry joined NuVasive at a critical period in 2018. Now, the company is building out its portfolio of surgical tools, adding a digital surgery platform, planning its own move into robotics and finally making training much easier for its surgeons through new facilities, both real and virtual. Danielle Kirsh, senior editor, and Jim Hammerand, deliver the highlights from this month’s Medical Design and Outsourcing Magazine, our Women in Medtech issue. Danielle reveals some disheartening news about jobs and research dollars going to women while Jim shares hopeful details from some of the profiles. Chris Newmarker, executive editor, identifies this week’s Newmarker’s Newsmakers – Avail Medsystems, Integra Lifesciences, GE, Medtronic and NuVasive. Subscribe to this podcast on all major podcast applications.

The surgical robots are back in this episode of the DeviceTalks Weekly Podcast. First we’ll speak with Megan Rosengarten, president of robotics at Medtronic, about what the CE Mark for the Hugo surgical robot system means for current and future applications. Then, we speak with Ivan Tornos, COO of Zimmer Biomet, about that company’s broad technology offerings include ZBEdge, PersonaIQ Knee Implant, and other digital data collectors. Tornos says Zimmer Biomet intends to be the boldest company in the medtech industry. Chris Newmarker is back to deliver this week’s Newmarker’s Newsmakers – Intuitive Surgical, Xenter, Moderna, Medtronic, and Johnson & Johnson. Associate Editor Sean Whooley joins in on the fun. Subscribe to this podcast on all major podcast applications.

The urology specialty faces a critical moment, with 10 urologists ready to retire for every new urologist entering the field. That puts the onus on medical device companies to develop faster, safer and more efficacious ways to break down kidney stones, shrink enlarged prostates and handle other critical treatments. In this week’s episode, we’ll speak with Meghan Scanlon, SVP and president, Urology and Pelvic Health at Boston Scientific about that company’s growing pipeline bolstered by the acquisition of Lumenis. This episode was sponsored by KNF Neuberger. We’ll also connect with the leaders of Zenflow – CEO Nick Damiano and President Susan Stimson – about the start-up’s minimally invasive treatment for urinary obstruction caused by enlarged prostate, or benign prostatic hyperplasia (BPH). Finally, we have all-hands (or most hands) on deck for this episodes Newmarker's Newsmakers. Jim Hammerand, managing editor of Medical Design and Outsourcing, talks about Koya Medical and Hologic. Associate Editor Sean Whooley shares his insights on Varian and Explorer Surgical. Pharma Editor Brian Buntz gives us the latest on the never ending saga of Covid-19 booster approval. Subscribe on all major podcast applications.

In this first episode of the new IntuitiveTalks Podcast, we’ll start right at the beginning. CEO Gary S. Guthart recalls how a court side basketball conversation led to his introduction to the early form of a surgical robot and convinced him to join. He also shares his expectations for the surging surgical robotics field, including how the company will view emerging competition. This episode is sponsored by Tegra Medical.

Co-hosts Tom Salemi and Chris Newmarker announce the newest member of the DeviceTalks Podcast family - IntuitiveTalks!

Get it? Attractive? Magnets. Yeh, we’ll, we’re tired from putting this monster podcast episode together but it’s so, so good. You’ll hear from David Fischel, CEO of Stereotaxis, a 30-plus year old medtech that’s going through a quiet but deliberate reboot. Fischel says he took the company over because Stereotaxis’ magnetic robotic surgery system makes interventional surgery safer, an assertion supported by Daniel Cooper, MD, associate professor at Washington University School of Medicine. Stereotaxis appears to be on the cusp of something big. Then, Alberto Rodriguez-Navarro, MD, tells us why he sold everything to move from his native Chile to move to Silicon Valley and start Levitra Magnetics. The company is anticipating FDA approval for its own robotic system that could help hospitals overcome staffing shortages during laparoscopic procedures. We’ll also hear our sponsor Futek explain how its miniaturized sensors are advancing robotic surgery. Chris Newmarker, executive editor of life sciences, delivers the week’s big news featuring Siemen Healthineers, LumiraDx, Boston Scientific, Abbott and Medtronic. Senior editor Danielle Kirsh updates us on the Theranos trial. Subscribe to this podcast on all major channels.

This episode of the DeviceTalks Weekly Podcast draws from two realities First, Russell Powers, worldwide president, shoulder reconstruction, sports medicine, and spine at DePuy Synthes details how the company’s new Inhance Shoulder system will help the company grab market share in the increasingly competitive space. Later, we meet Dr. Justin Barad, CEO of OssoVR, on his own turf, conducting an interview in OssoVR’s virtual reality training platform. In the interview, Dr. Barad demonstrates why virtual reality training help alleviate the growing demands on surgeons while also improving performance. Chris Newmarker, executive editor of life sciences, identifies this week’s Newmarker’s Newsmakers including Abbott, Medtronic, and Vicarious Surgical. Senior editor Danielle Kirsh also shares her insights on the ongoing Theranos trial, including damaging testimony from General James Mattis. Subscribe to this podcast on all major channels!

Zoll Medical’s acquisition of Itamar Medical is just latest sign of the opportunity diagnosing and treating sleep apnea presents to medical device companies, especially following the CPAP machine recall issued by Philips Respironics earlier this summer. This week, we’ll talk with two of the leaders in this increasingly competitive market. First, we’ll reconnect with Tim Herbert, CEO of Inspire Medical Systems, to learn how that neurostimulation company is working to serve patients seeking an alternative to CPAP machines. This is our second visit with Tim Herbert. You can find his earlier interview on DeviceTalks.com. Then we welcome Michael “Mick” Farrell, CEO of ResMed, the leading provider of CPAP machines. Farrell explains why the apnea market is growing and what this means for the future of ResMed, which has grown into other respiratory businesses. Chris Newmarker returns! The executive editor of life sciences at MassDevice presents his Newmarker’s Newsmakers including Zoll, Itamar, Medtronic, Medicrea, iRhythm, Zimmer and its new spinout, ZimVie. We also discuss CMS’s disappointing backtrack on reimbursing innovative technologies. Danielle Kirsh, senior editor of life sciences, also presents a short report on the trial of Theranos founder Elizabeth Holmes.

Edward Lifesciences’ acquisition of Percutaneous Valve Technologies helped mark the birth of one of medtech’s great game-changers – the development of the transcatheter aortic valve replacement. In this week’s episode, Stanton Rowe, the former CEO of PVT, will walk us through the early days of TAVR, including the enormous doubt the start-up faced as it developed the technology. He also explained how Edwards came to acquire the start-up, which had strong interest from Medtronic, Boston Scientific, and others. Rowe, who is now CEO of the NXT Biomedical incubator, also offers some provocative thoughts on the origins of medtech innovation (and explains why he misses medical device conferences.) Larry Wood, corporate vice president at Edwards Lifesciences, will explain why Edwards opted to pursue PVT rather than continue to develop its own TAVR technology. He also explains why the clinical trial testing of the valve now known as Sapien was so difficult and how he rewrote the compensation packages for his TAVR sales team to help build confidence in the new technology. Scan the QR code for more information about our upcoming DeviceTalks Tuesday discussion with Sagentia! You can subscribe to this podcast on most major podcast players including Amazon, Apple, Google, and Spotify.

This week, DeviceTalks Weekly Podcast examines the single-use endoscope market. We’ll hear from market leaders Ambu and Boston Scientific in a replay of interviews we conducted in September 2020. Guests include Ambu’s CEO Juan Jose Gonzalez and Stephen Block as well Boston Scientific’s Endoscopy executives Dr. Brian Dunkin, chief medical officer, and Unit President David Pierce. You’re also invited to participate in a discussion led by TE Connectivity on Tuesday’s DeviceTalks Tuesday. Chris Newmarker, executive editor of life sciences at MassDevice, presents this week’s top Newmarker’s Newsmakers – Abbott, Boston Scientific, Medtronic, Johnston & Johnson, Auris and Amazon. Subscribe to this podcast on Amazon, Google, Apple, Spotify and other major apps.

New therapeutic approaches require fresh perspectives, and few perspectives were as fresh as Dr. Steven Mickelsen, the developer of a potentially paradigm shifting cardiac ablation treatment – pulse field ablation. Dr. Mickelsen, a high school dropout turned musician, fell deep enough in love with electrophysiology to go back to school, obtain a medical degree, and put his inclination to tinker to work in developing a new type of ablation. In this podcast we’ll walk down the path that led Dr. Mickelsen to create Farapulse, the early pioneer in this form of energy that now belongs to Boston Scientific. Dr. Mickelsen left the company a few years ago but he’s resumed his work helping Acutus Medical bring their technology to the market. He serves as that company’s chief translational science officer. In our second talk, we connect with Dr. Kenneth Stein, senior vice president and CMO of Boston Scientific’s cardiac rhythm management business. Dr. Stein allows us to pick up where Farapulse is leaving off, explaining why Boston Scientific bought the company now and what the plans are for the ablation systems, which has CE Mark but still requires FDA approval. Dr. Stein also shares advice for those physicians who may want to join a corporation. We also bring in Medtronic’s Rebecca Seidel, president of cardiac Ablation Solutions, and Dr. Robert Kowal, vice president of medical affairs and CMO at the cardiac rhythm and heart failure business. In this excerpt from our recent MedtronicTalks Podcast, Seidel and Dr. Kowal give a quick update on that company’s pulse field ablation technology. This week’s Newmarker’s Newsmakers is delivered by Senior Editor Danielle Kirsh and Associate Editor Sean Whooley including news from Ultrahuman, Johnson & Johnson, ResMed, Abiomed, and Abbott. Subscribe to this podcast on Amazon, Apple, Google and Spotify and other leading podcast apps.

Let's get interventional. This week, we talk with leaders from Abbott and Cordis about their plans to advance of medtech's stablest business. Duke Rohlen, executive chair, will explain to co-host Tom Salemi why he led the purchase of Cordis from Cardinal. Meanwhile, Dr. Nick West, CMO and DVP of vascular at Abbott, updates Associated Editor Sean Whooley on the Xience pipeline. This week's Newmarker's Newsmakers brings the big news from Abbott, Heartflow, Intersect ENT, Intuitive, Medtronic, Philips, and Resmed. Subscribe to this podcast on all major podcast applications!

This week’s episode focuses on the entrepreneurs. We open up with an interview with Andy Doraiswamy, founder and CEO of Koya Medical, a company he founded to help find a therapy for his ailing father. Then we revisit with Dr. Todd Brinton, chief scientific officer and corporate vice president at Edwards. This interview initially ran in May 2020 but we’re playing it again to amplify the unusual path that entrepreneurs take to find success.

This week's episode focuses on new hope for people with diabetes. Brad Paddock, CEO of CeQur, explains how its "wearable pen" can deliver insulin in a better way while Sean Salmon, head of Medtronic's diabetes business, reviews that company's growing portfolio. He also gives insights on its intriguing partnership with the private equity group, Blackstone. Chris Newmarker, executive editor of life sciences, drops a weighty Newmarker's Newmakers featuring stories from Hillrom, Baxter, NeuroMetrix, Philips, Medtronic and BD. Subscribe to this podcast on all major podcast apps.

The bioelectronics industry is poised to take off so we visited with Carolina Aguilar, CEO/Co-founder, INBRAIN Neuroelectronics about the field's potential. Chris Newmarker, executive editor of life sciences at MassDevice, delivers his Newmarker's Newsmakers highlighting news from Dexcom, NeuroMetrix, Nevro, Ancora and the Galien foundation. Subscribe to this podcast on Google, Amazon, Apple, Spotify and other major podcast channels.

Vicarious Surgical and CMR Surgical recently combined to raise over $1 billion from public and private investors. Big money clearly as found surgical robotics. Now what? We connect with Per Vegard Nerseth, the new CEO of CMR. Nerseth comes to CMR from the robotics industry, so he brings deep industry understanding of what it will take to get CMR to the next level. The company closed on $600 million for a Series D, which is likely the largest private medtech investment in history. Later, we reconnect with Adam Sachs, co-founder and CEO of Vicarious Surgical. Sachs walks us through the process of merging with a SPAC (not for the faint-hearted.) With over $400 million in hand, Vicarious is bringing in senior talent and moving to a legacy filled new HQ to prepare for its next stage. Chris Newmarker, executive editor of life sciences at MassDevice, brings his Newmarker's Newsmakers highlighting news from Stryker, Heartflow, Hillrom, BardyDx, TransMedics and Imperative Care. Subscribe to this podcast on every major podcast channel!

This week we’ll focus on investor insights. First, we’ll talk with Danielle Antalffy, managing director at SVB Leerink. Antalffy covers most of the major medtechs but we’ll focus on a new report she issues on sugaring home-based dialysis business. What does this mean for Outset specifically? More broadly, do other medtechs need to build out their at-home/connectivity function? Also, what does NeuroPace’s success mean for other medtech companies. In a follow up to our interview with Dr. James Min, CEO of Cleerly Health, we talk with two venture investors in the early heart attack risk detection company. Justin Klein, MD, of Vensana Capital walks us through the steps he took before leading the company’s recent $43 million Series B round. Tripp Peake of LRV Health explains why the company interests his venture firm’s limited partner base. This is an opportunity for entrepreneurs to better understand the venture capital due diligence process. Chris Newmarker, executive editor of life sciences, delivers his Newmarker’s Newsmakers brings top news from Conformis, Stryker, Siemens Healthineers, Abbott, Medtronic and Levita Magnetics. LIKE! FOLLOW! SUBSCRIBE! We’re on most major podcast channels.

In this week's DeviceTalks Weekly Podcast, Minnetronix CEO Jeremy Maniak explains how the CMO is using internal know how to develop medical devices that can be sold by outside partners. We also hear from Dr. James Min of Cleerly Health about that company's start and the process that went into raising $43 million. Chris Newmarker, executive editor of life sciences at MassDevice, is back to deliver his NewmarkersNewsmakers including news from Costa Rica, Vicarious Surgical, Ethicon, Medtronic and ResMed. Subscribe to this podcast today on all major podcast channels.

Nicole J. Walker, managing partner, Arboretum Ventures, tells a unique medtech story that begins with her sick grandfather and follows up with her refusal to remove her foot from the door at Advanced Cardiovascular Systems. She says she learned early on that she may not always have all the answers when making a decision but she would have the instincts and mettle to push through. This combination moved through jobs at Guidant, Abbott, Baird and now Arboretum Ventures where she sees an enormous opportunity finding medical device companies.

A year ago, Geoff Martha took over as CEO of medtech's large single company. With the sector in lockdown, the company still undertook a massive reorganization and moved to adopt a new "Medtronic Mindset" that would favor the bold. In this interview, Martha reviews Year 1, sharing some positive outcomes and disappointments. Chris Newmarker, executive editor of life sciences, delivers his Newmarkers Newsmakers featuring items from Abbott, Amazon, CVRx, Medtronic, and migraines. Subscribe on all major podcast platforms - Apple, Google, Amazon, Spotify.

In this week’s podcast, Chris Newmarker, executive editor of life sciences, speaks with Laura Rector, Smith + Nephew’s vice president of ambulatory surgery centers and digital health, about the company’s ARIA care management platform. The system uses 3D imaging, artificial intelligence and other tools to help patients recover more quickly from large joint replacement surgery. What’s next for the ortho leader? Meanwhile, Kaila Krum, managing director of Truist Securities, delivers insights on two major stories of the week – the decision by Mike Coyle to leave the CEO post at iRhythm and Medtronic’s decision to pull its Heartware HVAD off the shelves. Those two stories topped this week’s Newmarker’s Newsmakers, which also include items featuring Abbott, Abiomed and the FDA. Subscribe on Google, Amazon, Apple, Spotify, and other leading podcast channels.

This week we’ll explore innovation and social equity. First, we’ll hear a portion of an interview with Martha Ha, chief privacy officer and chief counsel of corporate governance, and Jon de Csepel, CMO, vice president, medical affairs of the Americas. The pair will explain how the company is reaching out to employees of Asia and Pacific Island and helping them to understand how to better work within the corporate culture. The entire interview can be heard in the latest MedtronicTalks Podcast Josh Makower, MD, is our closing keynote guest. Makower quite possibly invented modern day medtech innovation. In this interview, Makower shares his earliest inventions – kind of mind-blowing – and how his early work at Pfizer helped him create the innovation process used today by biodesign programs across the world, including Stanford Biodesign where Dr. Makower will take over as director this fall. This interview is essential for any individual or organization that wants to innovate. Chris Newmarker, executive editor of life sciences at MassDevice, returns to the podcast with a Newmarker’s Newsmakers that highlights COVID-19, Rapid Medical, iRhythm, Elizabeth Holmes and Medtronic. Tom Salemi also has big news! Subscribe to this podcast on Apple Podcasts, Google, Spotify, Amazon and other major platforms.

This week, the DeviceTalks Weekly Podcasts delivers some learning. First, Dr. Nick West, CMO & divisional VP of global medical affairs at Abbott’s vascular business, discusses the European launch of the company's new coronary imaging platform. Dr. West explains how the AI-powered platform works and the benefits it offers for decision-making during coronary stenting procedures. He also delves into the AI-based technology behind the platform and the direction both imaging and medtech as a whole are heading with AI. Then, Mike Carrel, CEO and president of AtriCure, explains how the company became a force focusing on the atrial fibrillation (Afib) and left atrial appendage (LAA) markets. Carrel walks listeners through the company’s efforts to expand its reach into the connected pain management market. But then he makes a strong case building out its Afib pipeline which includes the EPi-Sense System, which in April received FDA approval to treat patients diagnosed with long-standing persistent atrial fibrillation. Sean Whooley, associate editor at MassDevice, delivers this week’s Newmarkers Newsmakers with updates from Google, Memic (SPAC ATTACK!), Medtronic, Teleflex, and Abbott.

Jeff Mirviss, executive vice president of Boston Scientific’s peripheral business, explains why the specialty’s name doesn’t really reflect the importance of arteries, veins and other “highways” that his business group is addressing. Mirviss explains where the peripheral business is headed, and why Boston Scientific is uniquely positioned to address the business. He also shares lessons learned over his 20-plus years at Boston Scientific including the challenges presented by the Guidant acquisition and the new spirit infused by CEO Michael Mahoney. We also speak with Eric Kolodziej, corporate vice president and global head quality and regulatory affairs at Hologic, about how clinical trial management is changing. What role will real world evidence play going forward, and how will Hologic and others follow up on the record number of EUA’s issued over the past year by the FDA. Chris Newmarker, executive editor of life sciences at Mass Device, delivers his Newmarker’s Newsmakers bringing news from Medtronic, Abbott, Zimmer Biomet and Shockwave. Pharma Editor Brian Buntz also sits in the virtual booth to talk about the new Pharma 50 report compiled by our editorial team. Subscribe today on most major podcast applications

In this episode, two of the executives leading Medtronic’s push into robotics surgery update listeners on the progress and potential of Medtronic's MAZOR X Stealth and Hugo RAS system platforms. Megan Rosengarten, president of surgical robotics, says HUGO is poised to deliver surgeons newfound capabilities and options. The company hopes to begin selling the system later this year after filing for a CE Mark in Europe and an IDE with the US Food and Drug Administration. Chris Newmarker, executive editor of life sciences at MassDevice, delivers this week’s Newmarker’s Newsmakers including reports from Neuroelectrics, Medtronic, and Apple. Danielle Kirsh, senior editor, also updates listeners on her recent report on four catheter-based devices to watch for this year. Also, an update from our underground medtech analyst – Barry the Groundhog. Please subscribe on all major podcast channels - Amazon, Apple, Google, Spotify

Can Proximie bring safer surgery to the wider world? How is Getinge answering call for ventilators? In this week’s podcast senior executives from Getinge and Proximie – two very different sized companies – explain how the COVID-19 pandemic accelerated their business. In the opening keynote conversation, Eric Honroth, president, Getinge North America, explained how the company more than doubled its production of ventilators in 2020. He also discusses recent FDA clearances for two lines of critical devices. In our closing keynote, Dr. Nadine Hachach-Haram, CEO and founder of Proximie, says the start-up reached its 2023-24 projected size in just a few months as hospitals and medical device companies sought the ability to collect surgeons to the outside world. Dr. Hachach-Haram, a reconstructive surgeon, gives a detailed account of how a growing shortage of surgeons convinced her to start a technology company. She also shares how the technology ultimately restored the life of someone very close to her. Chris Newmarker, executive editor of MassDevice, offers up his Top 5 Newmarker’s Newsmakers including news about human-monkey embryos, Abbott, Stryker, Medtronic and DJO. Don't forget to subscribe to this podcast! And our new MedtronicTalks podcast.

In this podcast, iRhythm CEO Mike Coyle discusses his decision to join the digital health leader in January. Coyle’s had to hit the ground running as iRhythm manages some challenging decisions from regional Medicare payors but he also sees great opportunity for the company’s ZIO platform across the healthcare spectrum. In this conversation, Coyle discusses • How he came to join the Medtech industry. • The potential for its ZIO cardiac monitoring technology • How the company is dealing with a disappointing reimbursement • How the company will pursue the large asymptomatic market • What’s expected to come from the company’s partnership with Verily We also introduce the newest member of our DeviceTalks Podcast family. Catch an excerpt of the first episode in this week’s podcast. Subscribe to hear future episodes. Caffeine-fueled Chris Newmarker, executive editor of life sciences at Mass Device, takes a break from earnings week to roll out a powerful #newmarkersjnewmakers bringing news from Zimmer Biomet, Stryker, Emergent Biosolutions, Intuitive Surgical, Medtronic and NeuroPace. Subscribe on all major podcast players.

This week, Liane Teplitsky, vice president and general manager of worldwide robotics at Zimmer Biomet, shares her excitement for the burgeoning data business emerging in orthopedics. Teplitsky, an engineer who built her medtech career in the cardiac R&D and sales at St. Jude and Abbott, walks us through the interconnected offerings of Zimmer’s ZBEdge suite of digital and robotics technologies. We also speak with Achuta Kadambi, assistant professor to the UCLA Samueli School of Engineering, about a column he contributed to Science suggesting physics may be causing medical devices to perform at varying levels in people of different races. Kadambi explains his own work in the field and suggests how medical device developers may want to move forward in the future. Go here to read the MDO article on this topic and find the link to the Science column. https://www.medicaldesignandoutsourcing.com/ucla-prof-racial-bias-in-medical-devices-based-in-physics/ Chris Newmarker of MassDevice reports on another SPAC ATTACK in this week’s Newsmarker’s Newsmakers – Siemens Healthineers, Varian, Zoll, Respicardia, Endologix, PQ Bypass, Vicarious Surgical, Medline Industries. And find out what happened to that chicken.... Subscribe today on all major podcast channels.